EVIO Inc. Releases Preliminary Fourth Quarter 2018 Results - Seite 2

“On the Canadian front, Health Canada finally announced on November 8, 2018 the long awaited mandated independent pesticide testing that goes into effect January 2, 2019. We are pleased to say we are in final stages of completing the installation of CDN$1.1M of new laboratory equipment at our facility in Edmonton, Alberta. This positions EVIO as one of a few licensed laboratories that may fully serve the testing requirements of Canadian licensed producers. We look forward to providing our compliance and safety services across Canada where as of October 17, 2018, cannabis use is federally regulated for both medicinal and recreational purposes.”

Mr. Waldrop finished up with, “We could not be more pleased with our most recent results and the overall performance of our entire team. We are working together to pioneer a new industry that is in a constant state of political and regulatory changes. The EVIO team has had to continually adapt and reengineer itself to remain both in compliance in a highly regulated industry and competitive in a new and everchanging marketplace. We want to thank each of you for your support and look forward to sharing more with you in the coming weeks.”

About EVIO Inc.

EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company's EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply. The Company's EVIO Biosciences Division is dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system.

For more information, visit www.eviolabs.com.

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact maybe considered to be forward-looking statements. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com.